Speciality: Pediatrics
Description:
A warm welcome to all the medical professionals in this interesting session of Turner syndrome management in female patients. In this webinar, the speakers, Dr. Jayashree Gopal, and Dr. Usha Sriram has shared the important facts associated with Turner syndrome .
Turner syndrome is a growth deficit condition that affects only females. It occurs when one of the X chromosomes (sex chromosomes) is missing or partially missing in females. Turner syndrome can cause a variety of medical and developmental problems, including short height, failure of the ovaries to develop and heart defects.
As it is a chromosomal condition Turner syndrome can affect development in females. The most common feature observed in Turner syndrome is short stature, which becomes evident by about age 5. An early loss of ovarian function (ovarian hypofunction or premature ovarian failure) is most commonly seen.
Therefore, you are going to have an overall knowledge regarding Turner syndrome. Listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Recurrent UTIs impact eGFR in children with vesicoureteral reflux
2.
novel approach to test the toxicity of cancer drugs.
3.
A protein with new anticancer activity has been identified
4.
What Dolph Lundgren's journey from terminal diagnosis to 'cancer free' can tell us about cancer care
5.
Glioma Outcomes Shaped by Subtype More Than Tx Sequence
1.
Managing KRAS Inhibitor Toxicities: Focus on Rash and Beyond
2.
Teaching Hematology Through Morphology-Based Learning
3.
What You Need to Know about Hairy Cell Leukemia: A Comprehensive Guide
4.
Immune Recovery After Intensive Cancer Therapy
5.
Cancer Prehabilitation and Functional Recovery Pathways: An Evidence-Based Review
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I
2.
Blood Clotting Disorders Explained
3.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
4.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation